Insider Transactions in Q1 2023 at Stoke Therapeutics, Inc. (STOK)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 27
2023
|
Edward M. Md Kaye CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.77%
|
$0
$0.6 P/Share
|
Feb 06
2023
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,235
-7.63%
|
$92,350
$10.02 P/Share
|
Feb 03
2023
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,763
-3.02%
|
$37,630
$10.03 P/Share
|
Feb 02
2023
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
267
-0.21%
|
$2,670
$10.0 P/Share
|
Feb 01
2023
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,705
-4.37%
|
$57,050
$10.02 P/Share
|
Jan 31
2023
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
200
-0.15%
|
$2,000
$10.0 P/Share
|